💊Dainippon Sumitomo announces the launch of “Seebri ™ Neohaler®” for the treatment of chronic obstructive pulmonary disease (COPD) in the United States 20171020 Friday October 20th, 2017By Tokio X'press JPN, Pharmaceutical Dainippon Sumitomo
